Extended Use of Valsartan and Other Angiotensin-Receptor Blockers May Increase Cancer Risk: Study
Valsartan and similar hypertension drugs may carry an increased risk of cancer with long-term use, according to the findings of a new study.
Valsartan and similar hypertension drugs may carry an increased risk of cancer with long-term use, according to the findings of a new study.
Nearly 80 lots of Irbesartan and Irbesartan/HCTZ combination tablets are being recalled due to the presence of a potentially cancer-causing chemical.
A growing number of international recalls of irbesartan products is raising concerns about a potentially cancer-causing mutagen called azido, which may result in another global hypertension drug recall similar to…
Several years after recalls were issued for nearly all versions of valartan, losartan and irbesartan in the United States, due to high levels of cancer-causing chemical byproducts that contaminated the…
A new study questions whether hypertension drugs have a negative impact on patients with COVID-19 infections.
A new study finds that valsartan and similar drugs do not increase the risk of poor outcomes from COVID-19.
New study questions whether hypertension drugs increase severity of COVID-19.
Some researcher warn that blood pressure medications like valsartan and Benicar could increase the severity and lethality of the coronavirus.
Plaintiffs say defendants are destroying recalled, tainted pills which could serve as crucial evidence in valsartan recall lawsuit trials.
A new study suggests there was confusion over which drugs to use following the initial valsartan recalls due to NDMA contamination.